Last update 21 Nov 2024

SL-901

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
PI3K family
Mechanism
Phosphatidylinositol 3-kinase family inhibitors
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
Solid tumorAdvanced Malignant Solid NeoplasmLung Cancer
Inactive Indication-
Originator Organization
UCB SAUCB SA
Active Organization
UCB SAUCB SAStemline Therapeutics, Inc.Stemline Therapeutics, Inc.Menarini Von Heyden GmbH
Inactive Organization
UCB Pharma GmbHUCB Pharma GmbH
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SL-901
NCT05382936 / CompletedPhase 1
A Phase 1, Open-label, Dose-escalation Study of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors
100 Clinical Results associated with SL-901
Login to view more data
100 Translational Medicine associated with SL-901
Login to view more data
100 Patents (Medical) associated with SL-901
Login to view more data
100 Deals associated with SL-901
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
GB
Stemline Therapeutics, Inc.Stemline Therapeutics, Inc.
19 Mar 2021
Lung CancerPhase 1-
UCB SAUCB SA
-
Solid tumorPhase 1-
UCB Pharma GmbHUCB Pharma GmbH
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free